Skip to content

Using 3D Imaging to Optimize Bifurcation Stenting

On-line 3-dimensional Optical Frequency Domain Imaging to Optimize Bifurcation Stenting Using UltiMaster Stent: OPTIMUM Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02972489
Enrollment
106
Registered
2016-11-23
Start date
2017-01-31
Completion date
2017-12-31
Last updated
2016-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bifurcation Lesion, Coronary Artery Disease

Brief summary

The primary purpose of this study is to determine whether bifurcation stenting guided by on-line three-dimensional optical frequency domain imaging (3D-OFDI) is superior to that with angiographic guidance by measuring incomplete stent apposition (ISA) in the bifurcation segment.

Detailed description

The recently developed optical frequency domain imaging (OFDI) can provide high quality resolution images of the coronary arteries. This new imaging system enhances the understanding of complex coronary lesions and the complex interaction between coronary devices and vessels by assembling/compiling 2-dimensional cross sections. This 3-dimensional reconstruction with strut segmentation becomes possible on-line in the TERUMO OFDI console with 3-dimensional imaging software, which enables stent enhancement and 3D reconstruction within one minute. This real time 3D OFDI will promote the utilisation of 3-dimensional assessment in the treatment of bifurcation lesions.

Interventions

DEVICE3D OFDI guidance arm

Subjects randomized to 3D-guidance arm will undergo optical frequency domain imaging (OFDI) assessment in the main vessel after re-wiring into the jailed side branch following stent implantation. If the position of the wire is not located in the optimal cell, further attempts to redirect the wire to the optimal cell will be performed, with subsequent OFDI acquisitions to confirm position in 2D and off-line 3D reconstruction. After procedure, OFDI is performed in the main branch.

DEVICEAngio guidance arm

In angiography-guidance group, wire recrossing into the side branch will be performed using conventional fluoroscopic/angiographic guidance. After finishing the procedure, OFDI is performed in the main branch but the results will be blinded to the operators.

Sponsors

Fujita Health University
CollaboratorOTHER
Erasmus Medical Center
CollaboratorOTHER
Terumo Corporation
CollaboratorINDUSTRY
Increase Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient is at least 18 years of age and signed Informed Consent 2. Subject has coronary artery disease involving a bifurcation with objective evidence of ischemia including patients with chronic stable angina, silent ischemia and non-ST segment elevation acute coronary syndrome (NSTE-ACS) 3. Subject is appropriate to be treated by PCI according to the local practice (operator's judgment or heart team decision) 4. Patients' residence is in the area covered by the hospital 5. Patients with angiographically significant stenosis (\>50 % by visual assessment) in de novo, native, previously unstented bifurcation lesion(s) including left main lesion, which is in operator's opinion appropriate to be treated by PCI with a single stent strategy 6. The size of main vessel matches available Ultimaster stent sizes (\<4.0 mm, and 2.0 mm by visual assessment) 7. The size of side branch is \>2.0mm in diameter by visual assessment 8. The sidebranch is treatable with a sidebranch fenestration and/or kissing balloon

Exclusion criteria

1. Pregnancy 2. Patients with ST elevation myocardial infarction 3. Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, sirolimus, contrast material 4. Known thrombocytopenia (platelet count\< 100,000/mm3) 5. Cardiogenic Shock 6. Significant comorbidities precluding clinical follow-up (as judged by investigators) 7. Major planned surgery that requires discontinuation of dual antiplatelet therapy 8. History of stenting in the target bifurcation lesion 9. Renal insufficiency (GFR/MDRD \<45 ml/min), which precludes in operator's opinion contrast injection during repeat OFDI pullback 10. Severely tortuous or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal optical frequency domain imaging (OFDI) or excessive risk of complication to place an OFDI catheter 11. Target lesion reference vessel diameter (RVD) \< 2.25 and \> 4 mm 12. Other: Patient is judged inappropriate by the attending physician

Design outcomes

Primary

MeasureTime frameDescription
Percentage of malapposed strutsat time of bifurcation PCI surgeryPercentage of malapposed struts assessed by OFDI in bifurcation segment of main vessel

Secondary

MeasureTime frameDescription
Incomplete stent apposition (ISA) area (mm²)at time of bifurcation PCI surgery
Minimum lumen area (mm²)at time of bifurcation PCI surgery
Mean lumen area (mm²)at time of bifurcation PCI surgery
Minimum stent area (mm²)at time of bifurcation PCI surgery
Incidence of fulfilling optimal recrossing criteria on 3D-OFDIat time of bifurcation PCI surgeryMeasured as a percentage
Mean protrusion area (mm²)at time of bifurcation PCI surgery
Maximum protrusion area (mm²)at time of bifurcation PCI surgery
Minimum flow area (mm²)at time of bifurcation PCI surgery
Mean flow area (mm²)at time of bifurcation PCI surgery
Mean stent area (mm²)at time of bifurcation PCI surgery

Countries

Japan, Netherlands

Contacts

Primary ContactYoshinobu Onuma
yoshinobuonuma@gmail.com(011)+31-10-704-0704

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026